Amendment to Regulation (EC) No 1289/2004
Article 2
In column 2 of the Annex to Regulation (EC) No 1289/2004, the words ‘Alpharma (Belgium) BVBA’ are replaced by ‘Pfizer Ltd’.
Commission Implementing Regulation (EU) No 118/2012 Article 2
Commission Implementing Regulation (EU) No 118/2012 Article 2
Other provisions in Commission Implementing Regulation (EU) No 118/2012
- Article 1: Amendment to Regulation (EC) No 2380/2001
- Article 3: Amendment to Regulation (EC) No 1455/2004
- Article 4: Amendment to Regulation (EC) No 1800/2004
- Article 5: Amendment to Regulation (EC) No 600/2005
- Article 6: Amendment to Regulation (EU) No 874/2010
- Article 7: Amendment to Implementing Regulation (EU) No 388/2011
- Article 8: Amendment to Implementing Regulation (EU) No 532/2011
- Article 9: Amendment to Implementing Regulation (EU) No 900/2011
- Article 10: Correction to Implementing Regulation (EU) No 532/2011
- Article 11: Transitional measures
CitationArticle 2 of Commission Implementing Regulation (EU) No 118/2012 (LawPlayer, data as of 2026-07-04)
© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.
What to look at next
Commission Implementing Regulation (EU) No 118/2012, full textThe complete text of this law, so you can read this section in contextEuropean Union legislationEU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and yearEuropean Union: what this database coversWhich datasets are here, which official source they come from, and how current they areEuropean Union overview